Know Cancer

or
forgot password

Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors


Phase 1
18 Years
N/A
Not Enrolling
Both
Head and Neck Neoplasms

Thank you

Trial Information

Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors


Inclusion Criteria:



1. Stage II - IV squamous cell carcinoma of the head-and-neck region, treated with
radiotherapy or radiochemotherapy with curative intent.

2. 18 years or older

3. Informed consent

Exclusion Criteria:

1. Patients who have undergone surgery as primary tumor therapy.

2. Patients treated with palliative intent.

3. Pregnancy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Correlation of 18F-FLT-PET-signal changes before and during therapy with treatment outcome (clinical response and local tumor control)

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Johannes HA Kaanders, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Radboud University

Authority:

Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Study ID:

049

NCT ID:

NCT00163176

Start Date:

July 2005

Completion Date:

December 2010

Related Keywords:

  • Head and Neck Neoplasms
  • cell proliferation
  • PET
  • radiotherapy
  • Neoplasms
  • Head and Neck Neoplasms

Name

Location